Zobrazeno 1 - 10
of 10
pro vyhledávání: ''
Autor:
Yoshiro Nakahara, Tsunekazu Hishima, Noriyuki Masuda, Makoto Saito, Masumi Ogawa, Jiichiro Sasaki, Tatsuru Okamura, Yukio Hosomi
Publikováno v:
Molecular and Clinical Oncology. 5:14-18
Little is known on the efficacy of erlotinib treatment in patients expressing wild-type epidermal growth factor receptor (EGFR). This study is a retrospective review of patients with non-squamous, non-small-cell lung cancer (NS-NSCLC) and wild-type E
Autor:
Hiroaki Satoh, Koichi Kurishima, Mio Kawaguchi, Tomohiro Tamura, Katsunori Kagohashi, Hiroko Watanabe
Publikováno v:
Molecular and Clinical Oncology. 4:628-630
Pemetrexed-containing chemotherapy has shown promise in the treatment of non-small-cell lung cancer (NSCLC). However, although adenosquamous cell lung cancer (ASCLC) is a type of NSCLC, the availability of studies investigating its response to pemetr
Autor:
Lin Su, Qingchuan Zhao, Hong-Tao Li, Wan-kun Zhu, Kun Li, Wei Xu, Hua Yang, Hong-Bin Liu, Xiaopeng Han
Publikováno v:
Biomedical Reports. 2:183-187
Elevated serum levels of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) are associated with poor prognosis in patients with gastric cancer. Little is known regarding the clinical benefits of combining celecoxib, a selective in
Publikováno v:
Oncology Letters
Current practice guidelines recommend the combination of chemotherapy and thoracic radiation for locally advanced non-small cell lung cancer (NSCLC). Previous meta-analyses have shown that concurrent chemoradiation (CCRT) may be superior to sequentia
Publikováno v:
Molecular and Clinical Oncology
The breast cancer resistance protein (BCRP) is a recently characterized xenobiotic half-transporter protein that acts as an energy-dependent efflux pump and may be associated with the multidrug-resistant phenotype. The aim of this study was to determ
Publikováno v:
Molecular and Clinical Oncology
The response rates to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) may vary and the risks may outweigh the benefits in poorly selected patients. This study investigated whether survivin expression, high-level
Publikováno v:
Experimental and Therapeutic Medicine
The aim of this study was to explore the correlation between mRNA expression of β-tubulin-III and stathmin in patients with stage II non-small cell lung cancer (NSCLC) and the chemosensitivity to Navelbine plus cisplatin (NP), as well as to provide
Publikováno v:
Oncology Letters
Small cell neuroendocrine carcinoma arising in the ureter is extremely rare; only a few cases have been previously reported in the literature. The current study reports the case of a 65-year-old female who presented with right-sided back pain. A mass
Publikováno v:
International Journal of Oncology. 38
Clusterin (also called APOJ, SGP-2, XIP8) has thus far been only partially characterized in lymphomas contrary to other types of cancer. Its expression has been reported only for anaplastic large cell lymphomas and, more recently, in mycosis fungoide
Publikováno v:
Oncology Reports.
Doxifluridine (5'-DFUR) is an anticancer drug converted to 5-fluorouracil (5-FU) by thymidine phosphorylase (TP). TP is an angiogenetic and platelet-derived endothelial cell growth factor. We evaluated the relation between TP expression and chemother